BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 140 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,603,699 | +4.2% | 650,240 | +3.6% | 0.03% | +17.2% |
| Q2 2023 | $4,419,056 | +17.1% | 627,707 | +38.7% | 0.03% | +26.1% |
| Q1 2023 | $3,774,812 | +24905.4% | 452,615 | +34319.4% | 0.02% | – |
| Q4 2022 | $15,096 | -99.4% | 1,315 | -99.3% | 0.00% | -100.0% |
| Q3 2022 | $2,495,000 | +501.2% | 198,043 | +404.9% | 0.01% | +366.7% |
| Q2 2022 | $415,000 | -83.2% | 39,222 | -74.2% | 0.00% | -85.7% |
| Q1 2022 | $2,473,000 | +1960.8% | 152,074 | +1648.2% | 0.02% | +2000.0% |
| Q4 2021 | $120,000 | -85.5% | 8,699 | -84.9% | 0.00% | -90.0% |
| Q3 2021 | $829,000 | -24.4% | 57,658 | -16.9% | 0.01% | -16.7% |
| Q2 2021 | $1,096,000 | +160.3% | 69,354 | +67.3% | 0.01% | +140.0% |
| Q1 2021 | $421,000 | -87.6% | 41,444 | -90.9% | 0.01% | -89.4% |
| Q4 2020 | $3,401,000 | +8402.5% | 456,564 | +3830.8% | 0.05% | +4600.0% |
| Q3 2020 | $40,000 | +1233.3% | 11,615 | +1559.3% | 0.00% | – |
| Q2 2020 | $3,000 | -92.3% | 700 | -96.4% | 0.00% | -100.0% |
| Q1 2020 | $39,000 | +333.3% | 19,600 | +653.8% | 0.00% | – |
| Q4 2019 | $9,000 | -91.2% | 2,600 | -90.4% | 0.00% | -100.0% |
| Q2 2019 | $102,000 | +13.3% | 27,016 | +143.6% | 0.00% | -33.3% |
| Q1 2019 | $90,000 | +12.5% | 11,092 | +11.6% | 0.00% | -25.0% |
| Q4 2018 | $80,000 | -41.6% | 9,937 | -44.5% | 0.00% | -42.9% |
| Q3 2018 | $137,000 | +69.1% | 17,894 | +26.0% | 0.01% | +75.0% |
| Q2 2018 | $81,000 | -31.4% | 14,200 | +1.3% | 0.00% | -50.0% |
| Q1 2017 | $118,000 | -12.6% | 14,016 | -70.7% | 0.01% | 0.0% |
| Q1 2016 | $135,000 | -76.4% | 47,804 | +24.8% | 0.01% | -71.4% |
| Q2 2015 | $572,000 | – | 38,290 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $27,230,770 | 26.28% |
| Prosight Management, LP | 2,408,135 | $17,049,596 | 5.40% |
| Kynam Capital Management, LP | 3,133,193 | $22,183,006 | 3.63% |
| Saturn V Capital Management LP | 982,458 | $6,955,803 | 2.91% |
| AlphaCentric Advisors LLC | 649,000 | $4,594,920 | 2.61% |
| TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $12,744,000 | 1.80% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 791,671 | $5,605,031 | 1.70% |
| Eversept Partners, LP | 2,479,103 | $17,552,049 | 1.48% |
| DAFNA Capital Management LLC | 652,000 | $4,616,160 | 1.44% |
| Avoro Capital Advisors LLC | 11,550,000 | $81,774,000 | 1.28% |